Pretreatment Tumor Growth Rate and Radiological Response as Predictive Markers of Pathological Response and Survival in Patients with Resectable Lung Cancer Treated by Neoadjuvant Treatment

SIMPLE SUMMARY: For patients with resectable non-small cell lung carcinoma (NSCLC), neoadjuvant nivolumab and chemotherapy are associated with increased major pathological responses and better event-free survival. Identification of earlier biomarkers associated with progression precluding surgery or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramtohul, Toulsie, Challier, Léa, Servois, Vincent, Girard, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453282/
https://www.ncbi.nlm.nih.gov/pubmed/37627186
http://dx.doi.org/10.3390/cancers15164158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453282/
https://www.ncbi.nlm.nih.gov/pubmed/37627186
http://dx.doi.org/10.3390/cancers15164158

Ejemplares similares